NCT06538155

Brief Summary

Out-of-hospital cardiac arrest (OHCA) affects 275,000 people in Europe every year. In Italy alone, 50,000 people experience OHCA annually, with only 9% surviving. Half of the survivors suffer severe brain damage. Immediate CPR and defibrillation by bystanders before the ambulance arrives can save lives, but often, CPR starts only when the ambulance gets there. Additionally, half of all OHCAs occur when the person is alone, causing delays in recognizing the emergency, calling for help, and starting lifesaving actions. Effective chest compressions and defibrillation are crucial but are often not done correctly or are not customized for each patient. Current guidelines recommend the same approach for everyone, which doesn't consider individual needs. To tackle these issues, we plan to develop artificial intelligence (AI) algorithms, smartphone apps, and new devices. Our main goal is to create tools and technologies to improve the recognition of OHCA and provide timely and effective interventions, ultimately reducing the impact of OHCA and improving survival rates. First, we aim to create an AI algorithm that can predict major cardiovascular events like heart attacks or cardiac arrests minutes, hours, or days before they happen. We will collect data from wearable devices to train and validate this algorithm, helping us identify individuals at risk. By alerting these individuals, they can seek emergency care and receive treatment before a cardiac arrest occurs. We will also work on recognizing OHCA cases from surveillance camera footage when they happen to people who are alone. Second, to increase the rate of CPR and defibrillation before ambulances arrive, we will develop a smartphone app that geolocates and alerts nearby citizens to act as first responders. The app will guide them on how to quickly find a defibrillator and use it. Third, to find the best spots on the chest for compressions and defibrillation, we will study chest scans from CTs and echocardiograms in both elective patients and cardiac arrest victims. This will help us understand the effects of compressing different heart structures and develop a sensor to determine the optimal positions for compressions and defibrillator pads. Our multidisciplinary team of clinicians, researchers, and engineers will conduct experimental, simulation, and observational studies to develop these technologies, evaluate their potential for patents, design a plan for their use, and test their effectiveness in preventing and recognizing OHCA. We believe that by improving each step in the chain of survival-preventing cardiac events, early recognition, timely CPR and defibrillation, and high-quality advanced resuscitation-we can significantly improve treatment times and reduce the global death and disability rates caused by OHCA.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
3mo left

Started Jan 2025

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
Jan 2025Aug 2026

First Submitted

Initial submission to the registry

July 31, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 5, 2024

Completed
6 months until next milestone

Study Start

First participant enrolled

January 27, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2026

Last Updated

August 6, 2025

Status Verified

August 1, 2025

Enrollment Period

1.5 years

First QC Date

July 31, 2024

Last Update Submit

August 5, 2025

Conditions

Keywords

out-of-hospital cardiac arrestcardiac arrestcardiopulmonary resuscitationextracorporeal cardiopulmonary resuscitation

Outcome Measures

Primary Outcomes (1)

  • Survival

    Hospital discharge (4 weeks for hospital admission)

Study Arms (3)

Wearable device users

Healthy volunteers (every adult individual with no history of cardiovascular events willing to contribute to the project) and patients who experienced major cardiovascular events (i.e., myocardial infarction or cardiac arrest). Both groups must have worn a wearable device or used a smartphone able to collect healthcare data and biosignals.

Device: Wearable device

Patients with cardiac arrest

Adults resuscitated after cardiac arrest or during ongoing cardiopulmonary resuscitation (CPR).

Other: Cardiopulmonary resuscitationOther: CT scan, TEE exam, or chest X ray

Patients who received a CT scan

Adults who received a chest CT scan for any reasons.

Other: CT scan, TEE exam, or chest X ray

Interventions

Wearable devices that are preferentially Food and Drug Administration (FDA) and/or Conformité Européenne (CE) marked

Wearable device users

Cardiopulmonary resuscitation

Patients with cardiac arrest

Chest CT scan, transesophageal echocardiogram (TEE) scans, or chest X ray

Patients who received a CT scanPatients with cardiac arrest

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

* Healthy volunteers (every adult individual with no history of cardiovascular events willing to contribute to the project) and patients who experienced major cardiovascular events (i.e., myocardial infarction or cardiac arrest). Both groups must have worn a wearable device or used a smartphone able to collect healthcare data and biosignals. * Patients ≥18 years resuscitated after cardiac arrest or during ongoing cardiopulmonary resuscitation (CPR). * Patients ≥ 18 years who received a chest CT scan for any reasons.

You may qualify if:

  • Age 18-70 years;
  • Being a healthy volunteer (i.e., an individual with no history of cardiovascular events willing to contribute to the project) or a patient (survivors and non-survivors) who experienced major cardiovascular events (i.e., myocardial infarction or cardiac arrest);
  • Users of a smartwatch or smartphone that continuously and automatically collect health data;
  • Informed consent.

You may not qualify if:

  • Impossibility to access/export data;
  • User did not wear the wearable device for periods longer than 24 hours;
  • User did not wear the wearable device in the 4 weeks preceding the event.
  • AIM 1.2 CARDIAC ARREST DETECTION FROM VIDEOS No patient involved.
  • AIM 2: TECHNOLOGIES TO INCREASE CPR AND DEFIBRILLATION USE BEFORE AMBULANCE ARRIVAL No patient involved.
  • AIM 3: PATIENT-TAILORED RESUSCITATION AIM 3.1: CLINICAL STUDY IN PATIENTS WHO RECEIVED CPR
  • Adults (≥ 18 years);
  • Patients suffering a non-traumatic cardiac arrest treated with chest compressions (both survivors and non-survivors);
  • Received a TEE, chest x-ray, or chest CT scan as the standard clinical assessment following cardiac arrest;
  • Informed consent.
  • \- Patients with severe thorax/mediastinal deformity.
  • AIM 3.2 CLINICAL STUDY IN PATIENTS WHO RECEIVED A CHEST CT SCAN
  • Adults (≥ 18 years);
  • Received a chest CT scan for any reasons;
  • Informed consent.
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

IRCCS Ospedale San Raffaele

Milan, 20132, Italy

RECRUITING

AOU Policlinico Federico II

Napoli, 80100, Italy

NOT YET RECRUITING

Azienda Ospedaliera Universitaria Vanvitelli

Napoli, 80138, Italy

NOT YET RECRUITING

MeSH Terms

Conditions

Out-of-Hospital Cardiac ArrestHeart Arrest

Interventions

Wearable Electronic DevicesCardiopulmonary Resuscitation

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Electrical Equipment and SuppliesEquipment and SuppliesResuscitationEmergency TreatmentTherapeutics

Study Officials

  • Alberto Zangrillo, MD

    IRCCS Ospedale San Raffaele

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Giovanni Landoni, MD

CONTACT

Tommaso Scquizzato, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof

Study Record Dates

First Submitted

July 31, 2024

First Posted

August 5, 2024

Study Start

January 27, 2025

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

August 31, 2026

Last Updated

August 6, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations